EverSource Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $709K | Buy |
1,749
+163
| +10% | +$66.1K | 0.03% | 358 |
|
2025
Q1 | $789K | Buy |
1,586
+133
| +9% | +$66.2K | 0.04% | 290 |
|
2024
Q4 | $756K | Sell |
1,453
-100
| -6% | -$52K | 0.04% | 291 |
|
2024
Q3 | $961K | Buy |
1,553
+1
| +0.1% | +$619 | 0.06% | 224 |
|
2024
Q2 | $952K | Buy |
1,552
+175
| +13% | +$107K | 0.06% | 220 |
|
2024
Q1 | $784K | Buy |
1,377
+65
| +5% | +$37K | 0.06% | 213 |
|
2023
Q4 | $697K | Sell |
1,312
-61
| -4% | -$32.4K | 0.06% | 207 |
|
2023
Q3 | $695K | Sell |
1,373
-104
| -7% | -$52.7K | 0.07% | 190 |
|
2023
Q2 | $771K | Buy |
1,477
+7
| +0.5% | +$3.65K | 0.09% | 188 |
|
2023
Q1 | $847K | Sell |
1,470
-120
| -8% | -$69.2K | 0.11% | 155 |
|
2022
Q4 | $876K | Sell |
1,590
-1,054
| -40% | -$580K | 0.13% | 128 |
|
2022
Q3 | $1.34M | Buy |
2,644
+1,943
| +277% | +$985K | 0.31% | 63 |
|
2022
Q2 | $380K | Buy |
701
+241
| +52% | +$131K | 0.1% | 183 |
|
2022
Q1 | $272K | Buy |
460
+71
| +18% | +$42K | 0.07% | 217 |
|
2021
Q4 | $259K | Buy |
+389
| New | +$259K | 0.07% | 187 |
|